Cannabis trial launched in patients with MSBMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7280.192/c (Published 27 January 2001) Cite this as: BMJ 2001;322:192
- Owen Dyer
The world's biggest clinical trial of the cannabis plant got under way this week at Derriford Hospital, Plymouth; the trial is looking at the control of pain and tremors in multiple sclerosis. Twenty patients were given their first doses of capsules containing cannabis oil, tetra hydro cannabinol, or placebo. After three months, if all goes to plan, the trial will be slowly extended across the country, eventually taking in 660 participants in 40 centres.
The cannabis in multiple sclerosis (CAMS) study is sponsored by the Medical Research Council and approved by …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial